Immuron (IMRN) Free Cash Flow (2016 - 2024)
Immuron (IMRN) recorded quarterly Free Cash Flow of -$2.6 million in Q4 2024, down 100.19% quarter-over-quarter from -$1.3 million in Q4 2023, and down 100.19% on a YoY basis from $1.3 billion in Q1 2024.
Immuron (IMRN) Free Cash Flow (2016 - 2024) Analysis & Trends
Immuron's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$2.6 million for Q4 2024.
- In Q4 2024, Free Cash Flow fell 100.19% year-over-year to -$2.6 million; the TTM figure through Sep 2025 stood at -$2.6 million (down 100.19% YoY), while the FY2025 annual figure was -$3.1 million, up 47.27% from the prior year.
- Free Cash Flow was -$2.6 million for Q4 2024 at Immuron, down from -$1.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$1.3 million in Q4 2023 to a low of -$2.7 million in Q4 2020.
- Historically, Free Cash Flow has averaged -$2.1 million across 4 years, with a median of -$2.3 million in 2021.
- The sharpest annual moves came in 2021 and 2024: Free Cash Flow climbed 26.8% in 2021, then tumbled 100.19% in 2024.
- A 4-year view of Free Cash Flow shows it stood at -$2.7 million in 2020, then gained by 26.8% to -$2.0 million in 2021, then jumped by 34.07% to -$1.3 million in 2023, then sank by 100.19% to -$2.6 million in 2024.
- The last three Free Cash Flow figures came in at -$2.6 million (Q4 2024), -$1.3 million (Q4 2023), and -$2.0 million (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.61 Mn |
| Dec 31, 2024 | -2.61 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Dec 31, 2021 | -1.98 Mn |
| Dec 31, 2021 | -1.98 Mn |
| Dec 31, 2020 | -2.70 Mn |
| Dec 31, 2020 | -2.70 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2018 | -424,940.00 |
| Dec 31, 2018 | -424,940.00 |
| Dec 31, 2017 | -2.48 Mn |
| Dec 31, 2017 | -2.48 Mn |
| Dec 31, 2016 | 1.67 Mn |
| Dec 31, 2016 | 1.67 Mn |